Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
Overview | Financials
Company Name | Lexicon Pharmaceuticals, Inc. |
Symbol | LXRX |
Currency | USD |
Price | 0.728 |
Market Cap | 263,021,579 |
Dividend Yield | 0% |
52-week-range | 0.62 - 3.73 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Lonnel Coats |
Website | https://www.lexpharma.com |
An error occurred while fetching data.
About Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD